KDR and neoplasm: Taken together, ourresults demonstrate that the pre-surgical efficacy of neoadjuvant therapy with an extracellular VEGFinhibitor on the primary tumor is more predictive of post-surgical survival outcomes than VEGFR TKItherapy and that the magnitude of tumor response after neoadjuvant therapy may be an independentsurrogate marker of overall post-surgical benefits.